Adipocyte iron regulates adiponectin and insulin sensitivity

Area of Science:

• Metabolic research
• Endocrinology
• Nutritional science

Background:

• Iron overload is linked to increased diabetes risk.
• Adiponectin, an insulin-sensitizing adipokine, is decreased in diabetic patients.
• Serum ferritin levels correlate inversely with adiponectin in humans.

Purpose of the Study:

• To investigate the effect of iron on adiponectin levels and function.
• To elucidate the molecular mechanisms by which iron influences adiponectin.
• To explore the therapeutic potential of iron reduction in metabolic dysfunction.

Main Methods:

• Human observational studies correlating ferritin and adiponectin.
• In vivo studies using high-iron-diet fed mice.
• In vitro studies on cultured adipocytes treated with iron.
• Genetic manipulation of ferroportin in mice.
• Clinical intervention with phlebotomy in humans.

Main Results:

• Increased ferritin and decreased adiponectin were observed in type 2 diabetic and obese diabetic subjects.
• High-iron diet and iron treatment reduced adiponectin mRNA and protein via FOXO1-mediated repression.
• Loss of ferroportin led to adipocyte iron loading, decreased adiponectin, and insulin resistance.
• Hemochromatosis (organismal iron overload) was associated with decreased adipocyte iron, increased adiponectin, and improved glucose tolerance.
• Phlebotomy in humans with impaired glucose tolerance increased adiponectin and improved glucose tolerance.

Conclusions:

• Iron plays a causal role in the risk of metabolic syndrome.
• Adipocytes modulate metabolism by regulating adiponectin in response to iron stores.
• Targeting iron levels presents a potential therapeutic strategy for metabolic disorders.